You are here: Home » News-CM » Companies » News
Business Standard

Board of Claris Lifesciences to consider September quarter results

Capital Market 

On 08 December 2016

Claris Lifesciences announced that pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, a meeting of the Board of Directors of the Company will be held on 08 December 2016, inter alia, to consider, approve and take on record the Unaudited Financial of the Company for the quarter ended 30 September 2016 as per Ind-AS.

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

RECOMMENDED FOR YOU

Board of Claris Lifesciences to consider September quarter results

On 08 December 2016

On 08 December 2016

Claris Lifesciences announced that pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, a meeting of the Board of Directors of the Company will be held on 08 December 2016, inter alia, to consider, approve and take on record the Unaudited Financial of the Company for the quarter ended 30 September 2016 as per Ind-AS.

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

image
Business Standard
177 22

Board of Claris Lifesciences to consider September quarter results

On 08 December 2016

Claris Lifesciences announced that pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, a meeting of the Board of Directors of the Company will be held on 08 December 2016, inter alia, to consider, approve and take on record the Unaudited Financial of the Company for the quarter ended 30 September 2016 as per Ind-AS.

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

image
Business Standard
177 22